CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MHRA (UK)
Original article

Send and receive information on adverse drug reactions (ADRs)

RegulatoryNeutral
AI Analysis

Summary

MHRA issued guidance on how marketing authorization holders should report signals and adverse drug reactions to medicines to the regulatory authority.

Importance:2/10
Sentiment:
0.00
regulatory guidanceadverse drug reactionspharmacovigilanceMHRA
Related Companies

Read the original article

Published by MHRA (UK) on September 14, 2026 4:11 PM

Read Original